THE HEPARIN STUDY
This is a clinical study to determine the best heparin dosing for children who are receiving hemodialysis

IRB approval

IRB Document (PDF)

Inclusion criteria
Acute and chronic pediatric hemodialysis patients 0-21 years of age at Loma Linda University

Exclusion criteria
Age greater than 21 years of age or concurrent treatment, receiving another medication that affects ACT values.

Protocol
Protocol Document (PDF)

Consent 
Consent Document (PDF)

Assent

Assent Document (PDF)

How to use the data entry forms

Baseline data form

ACT and Heparain data entry form